Injective climbs 12.04% facing resistance near $3.60 in recent range: weekly review

Injective climbs 12.04% facing resistance near $3.60 in recent range: weekly review
Injective rises 12.04% this week

Injective (INJ) is currently trading at $3.35, rising $0.36 (12.04%) over the past week. The asset remains below the weekly MA-20 ($3.83), MA-50 ($8.44), and MA-200 ($12.94), signaling continued medium- and long-term bearish momentum.

INJ price prediction
24H -3.97%
$4.11
48H -6.31%
$4.01
7D -24.07%
$3.25
1M 8.88%
$4.66
3M 146.03%
$10.53
6M 114.25%
$9.17
12M 93.69%
$8.29
Current price: $ 4.28 -0.27 5.96%
Real-time Data 16:40
Daily range 4.26 Arrow from to Icon 4.59
Weekly range 4.51 Arrow from to Icon 5.53
Loading...

Highlights

  • INJ remains under medium- and long-term bearish pressure, trading below major moving averages and dynamic resistance.
  • Momentum signals, including MACD and ADX, indicate a bearish bias with sellers maintaining control despite recent gains.
  • INJ is expected to consolidate between $3.10 and $3.60 over the next week, with downside or sideways movement most likely.

Persisting downside bias as indicators flag weak momentum this week

On the weekly (W1) chart, INJ is firmly beneath all major moving averages, with MA-20 at $3.83 serving as dynamic resistance and the Kijun line well above current price action. Key support lies at $3.10 while immediate resistance is at $3.60, reflecting this week's range. Momentum indicators remain broadly negative: MACD gives a "Strong Sell" signal, ADX suggests selling pressure, and RSI signals weakness at 36.25. Stochastic RSI at 100.00 indicates a risk of overbought conditions, while the CCI remains neutral, Awesome Oscillator lacks a clear trend, and Bull/Bear Power is slightly negative at -0.02.

Injective asset chart
Injective price dynamics. Source: TradingView.

Sideways consolidation expected as technicals cap upside next week

For the next 7 days, the forecast suggests INJ will likely trade between $3.10 and $3.60, consolidating within the upper part of this weekly range. Technicals do not indicate a high probability of an upside breakout, as no major indicator supports a Buy signal. The baseline scenario is continued sideways or slightly lower movement. A bullish push above $3.60 could trigger short-term momentum, but this is unlikely, while a break below $3.10 would reinforce prevailing bearish sentiment.

Jainam Mehta, market strategist, sees INJ consolidating after a 12.04% weekly gain, with medium- and long-term momentum still bearish by key moving averages. He notes that indicators like MACD, ADX, and RSI continue to signal weakness, despite price sitting near the top of this week’s range and no clear news catalyst. The analyst believes a move above $3.60 could prompt quick bullish reactions, but technicals do not support a breakout scenario. "With sellers holding the structure and most signals remaining negative, I favor watching for a break of $3.10 or a deeper retest before considering any contrarian entries this week."

Earlier, analysts noted that Injective was showing short-term bullish momentum while still facing lingering bearish pressure from longer-term trends. This week’s persistent weakness below all major moving averages reinforces those headwinds, and traders should watch for a break below $3.10 as confirmation of a continued downside scenario.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.